Internal Medicine, Medical Oncology · Jackson, MS
NPI
1013911668
Since 2005
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1227 N State St, Ste 101
Jackson, MS, 39202
Phone (601) 355-2485
Groups this clinician bills Medicare through
Medicare paid, 2024
$11.0M
464,459 services
Medicare patients, 2024
1,506
Average age 75
Drug cost, 2024
$9.7M
5,080 prescriptions
Company payments, 2025
$3,176
From 37 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tammy H Young was code J9271 (injection, pembrolizumab, 1 mg), 56,600 times for 53 patients. In total Tammy H Young billed 464,459 services in 177 codes, and Medicare paid $11.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 56,600 | 53 | $44.01 | $2.5M |
| J0185 Injection, aprepitant, 1 mg | Office | 40,950 | 77 | $1.28 | $53K |
| J9299 Injection, nivolumab, 1 mg | Office | 39,900 | 18 | $24.39 | $973K |
| J0897 Injection, denosumab, 1 mg | Office | 32,040 | 137 | $20.35 | $652K |
| J9264 Injection, paclitaxel protein-bound particles, 1 mg | Office | 28,400 | 18 | $10.75 | $305K |
| J9267 Injection, paclitaxel, 1 mg | Office | 23,520 | 25 | $0.08 | $1,799 |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 19,932 | 51 | $20.71 | $413K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 18,700 | 15 | $0.06 | $1,045 |
| J9075 Injection, cyclophosphamide, not otherwise specified, 5 mg | Office | 11,400 | 15 | $0.79 | $9,053 |
| J9022 Injection, atezolizumab, 10 mg | Office | 8,808 | 12 | $65.71 | $579K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 8,378 | 125 | $0.09 | $736 |
| J1930 Injection, lanreotide, 1 mg | Office | 8,160 | 11 | $33.51 | $273K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 6,100 | 117 | $0.69 | $4,231 |
| J9041 Injection, bortezomib, 0.1 mg | Office | 5,635 | 11 | $1.41 | $7,948 |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 5,570 | 14 | $36.74 | $205K |
By year: 2022 $9.0M for 515,134 services; 2023 $9.1M for 472,560 services; 2024 $11.0M for 464,459 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 4,614 | 1,300 | $7.54 | $35K |
| 80053 Clinical Chemistry | 4,322 | 1,292 | $10.26 | $44K |
| 36415 Venipuncture Blood Collection | 3,643 | 1,182 | $8.57 | $31K |
| 86300 Immunoassay | 1,461 | 635 | $20.13 | $29K |
| 84443 Clinical Chemistry | 596 | 194 | $16.46 | $9,810 |
| 83521 Immunoassay | 428 | 79 | $16.93 | $7,244 |
| 82728 Clinical Chemistry | 374 | 256 | $13.28 | $4,966 |
| 83550 Clinical Chemistry | 285 | 215 | $8.53 | $2,430 |
| 83540 Clinical Chemistry | 285 | 215 | $6.31 | $1,798 |
| 82378 Clinical Chemistry | 274 | 88 | $18.17 | $4,979 |
Medicare prescription drug claims, 2024
In 2024, the drug Tammy H Young prescribed most often to Medicare patients was Anastrozole, with 681 prescriptions and refills. In total Tammy H Young wrote 5,080 Medicare prescriptions that cost $9.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 681 | 1,288 | 161 | $7,816 |
| Letrozole Generic | 422 | 732 | 107 | $5,306 |
| Gabapentin Generic | 253 | 300 | 73 | $2,261 |
| Potassium Chloride Generic | 233 | 275 | 81 | $2,577 |
| Tamoxifen Citrate Generic | 222 | 451 | 60 | $3,129 |
| Ondansetron Hcl Generic | 140 | 142 | 69 | $917 |
| Verzenio Abemaciclib | 111 | 111 | 17 | $1.7M |
| Levothyroxine Sodium Generic | 111 | 151 | 22 | $493 |
| Prednisone Generic | 88 | 88 | 31 | $444 |
| Dexamethasone Generic | 84 | 105 | 23 | $1,396 |
| Imbruvica Ibrutinib | 83 | 83 | Under 11 | $1.3M |
| Prochlorperazine Maleate Generic | 82 | 82 | 57 | $892 |
| Acyclovir Generic | 79 | 119 | 20 | $875 |
| Exemestane Generic | 78 | 103 | 21 | $15K |
| Escitalopram Oxalate Generic | 77 | 107 | 23 | $344 |
Brand drugs: - claims; generic drugs: 4,200 claims; opioid claims: 79.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tammy H Young $3,176 ($3,176 in general payments such as food, travel and fees) from 37 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,200.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 19 | $1,200 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $263 |
| Celgene Corporation BMY | 10 | $230 |
| Janssen Biotech, Inc. JNJ | 5 | $191 |
| Gilead Sciences, Inc. GILD | 5 | $144 |
| Amgen Inc. AMGN | 1 | $103 |
| TerSera Therapeutics LLC | 3 | $97.88 |
| Pfizer Inc. PFE | 5 | $86.83 |
| Astellas Pharma US Inc 4503.T | 4 | $76.86 |
| Genentech USA, Inc. ROG.SW | 4 | $72.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.